Blogs

Latest Blogs

From Detection to Decision: Risk-Based Immunogenicity Testing

April 29, 2026

Immunogenicity describes treatment‑induced B‑ and T‑cell responses to therapeutics and represents a major hurdle for drug development, due to the potential impact on patient safety…

Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain

September 18, 2020

Inflammatory pain and hyperalgesia are considered functional features of an immune response, intended to protect tissue from further damage. At…

The prospect of immunotherapy for combating Alzheimer’s disease

September 18, 2020

Alzheimer’s disease is a progressive incurable neurodegenerative disorder that often leads to dementia, loss of motor function and cognitive decline.…

Rapid expansion of Treg cells protects from collateral colitis following a viral trigger

September 18, 2020

Regulatory T (Treg) cells are important for the induction and maintenance of peripheral tolerance; therefore, they are key in preventing…

Immune biomarkers in depression

July 24, 2020

The identification of clinically relevant and reproducible biomarkers in the field of psychiatry has received increased attention recently in order…

Faecal Calprotectin as a biomarker in Crohn’s disease

July 24, 2020

Crohn’s disease is an inflammatory bowel disease, which causes inflammation of your digestive tract with symptoms such as abdominal pain,…

Immune checkpoint inhibitors and MDSCs

July 16, 2020

The development of immune checkpoint inhibitors (ICIs) targeting lymphoid cells has remarkedly transformed therapeutic approaches for the treatment of cancer.…